Vektor democratizes cardiac ablations: vanguards of health care
“We started using AI to enhance algorithms and software to better be able to understand the data that’s in each patient’s ECG. And our goal with that was to bring forward personalized medicine in arrhythmia therapy and improve patient outcomes.” Vektor Medical’s CEO Rob Krummen explains when discussing vMap. In this Vanguards of Health Care episode, Krummen sits down with BI analyst Matt Henriksson for an in-depth interview about the expansion of its vMap system, which utilizes standard 12-lead electrocardiograph ECG reading to guide physicians to treat arrhythmia cases, including atrial fibrillation. He further discusses the strategy to democratize electrophysiology to get patients to ablation treatment as early as possible.
